Emil Kuriakose - Jan 30, 2025 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Medical Officer
Signature
/s/ David Strauss, as Attorney-in-Fact for Emil Kuriakose
Stock symbol
TERN
Transactions as of
Jan 30, 2025
Transactions value $
$0
Form type
4
Date filed
2/3/2025, 07:27 PM
Previous filing
Jan 6, 2025
Next filing
Apr 2, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to Buy) Award $0 +485K $0.00 485K Jan 30, 2025 Common Stock 485K $4.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.